Avian influenza virus neuraminidase protein (NA)

The **avian influenza virus neuraminidase protein** is a viral surface glycoprotein essential for the replication and infectivity of influenza viruses, including those with avian origin. It exists as a homotetrameric enzyme that cleaves terminal sialic acid residues from host cell and viral glycoproteins, a process critical for the release of newly formed viruses from infected cells and for the prevention of viral self-aggregation at the cell surface. There are nine main subtypes of neuraminidase (N1–N9) in influenza A viruses, with avian strains carrying various subtypes. NA is a primary target for anti-influenza drugs such as oseltamivir and zanamivir, which function as competitive enzyme inhibitors. Mutations in the neuraminidase gene can lead to resistance against these drugs, presenting a significant challenge for therapy and public health. The protein plays multiple roles in the viral life cycle, including modulating host-pathogen interactions and contributing to virus transmissibility and pathogenicity[1][3][4].

Other names

NeuraminidaseSialidaseInfluenza A virus neuraminidaseN1–N9 (refers to subtypes, e.g., N1 neuraminidase)

Inhibition of neuraminidase catalytic activity, preventing viral release from host cells